Literature DB >> 15494740

Association of haplotypes in the beta-chemokine locus with multiple sclerosis.

Tamara Vyshkina1, Yin Yao Shugart, Gary Birnbaum, Thomas P Leist, Bernadette Kalman.   

Abstract

Linkage studies in multiple sclerosis (MS) identified several susceptibility loci. One of these regions includes chromosome 17q11 where a meta-analysis of data from three genome scans suggested linkage. This region encodes a cluster of genes for beta-chemokines or CC chemokine ligands (CCLs), which may be involved in the development of MS lesions. Here we aimed to test if CCL alleles and haplotypes are associated with MS. Using methods of linkage and association, we observed deviations from the expected 50% transmission of haplotypes from unaffected parents to their affected children at CCL2, CCL11-CCL8-CCL13 and CCL3 within the investigated 1.85 MB chromosomal segment. Analyses of the linkage disequilibrium map support that variants with possible relevance to MS can be located within these subregions. Identification of MS associated CCL variants may have direct clinical significance, as it can lead to the design of small competitive antagonists of these molecules with beneficial effects in the treatment of patients with early and active disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15494740     DOI: 10.1038/sj.ejhg.5201295

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  8 in total

1.  Haplotypes within genes of beta-chemokines in 17q11 are associated with multiple sclerosis: a second phase study.

Authors:  Tamara Vyshkina; Bernadette Kalman
Journal:  Hum Genet       Date:  2005-08-03       Impact factor: 4.132

2.  Increased IL-23 secretion and altered chemokine production by dendritic cells upon CD46 activation in patients with multiple sclerosis.

Authors:  Adi Vaknin-Dembinsky; Gopal Murugaiyan; David A Hafler; Anne L Astier; Howard L Weiner
Journal:  J Neuroimmunol       Date:  2008-04-10       Impact factor: 3.478

3.  CCL genes in multiple sclerosis and systemic lupus erythematosus.

Authors:  Tamara Vyshkina; Andrew Sylvester; Saud Sadiq; Eduardo Bonilla; Andras Perl; Bernadette Kalman
Journal:  J Neuroimmunol       Date:  2008-07-03       Impact factor: 3.478

Review 4.  The chemokine network. II. On how polymorphisms and alternative splicing increase the number of molecular species and configure intricate patterns of disease susceptibility.

Authors:  R Colobran; R Pujol-Borrell; M P Armengol; M Juan
Journal:  Clin Exp Immunol       Date:  2007-10       Impact factor: 4.330

5.  CCR5Δ32 Polymorphism Associated with a Slower Rate Disease Progression in a Cohort of RR-MS Sicilian Patients.

Authors:  Rosalia D'Angelo; Concetta Crisafulli; Carmela Rinaldi; Alessia Ruggeri; Aldo Amato; Antonina Sidoti
Journal:  Mult Scler Int       Date:  2011-06-23

6.  Expression of Ccl11 associates with immune response modulation and protection against neuroinflammation in rats.

Authors:  Milena Z Adzemovic; Johan Öckinger; Manuel Zeitelhofer; Sonja Hochmeister; Amennai Daniel Beyeen; Atul Paulson; Alan Gillett; Melanie Thessen Hedreul; Ruxandra Covacu; Hans Lassmann; Tomas Olsson; Maja Jagodic
Journal:  PLoS One       Date:  2012-07-16       Impact factor: 3.240

7.  An investigation of polymorphisms in the 17q11.2-12 CC chemokine gene cluster for association with multiple sclerosis in Australians.

Authors:  Matthew J Bugeja; David Booth; Bruce Bennetts; Robert Heard; Justin Rubio; Graeme Stewart
Journal:  BMC Med Genet       Date:  2006-07-26       Impact factor: 2.103

8.  Involvement of beta-chemokines in the development of inflammatory demyelination.

Authors:  Ileana Banisor; Thomas P Leist; Bernadette Kalman
Journal:  J Neuroinflammation       Date:  2005-02-24       Impact factor: 8.322

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.